While behavioral symptoms are both early and prevalent features of behavioral variant frontotemporal dementia (bvFTD), they can be present in other types of dementia as well, including Alzheimer’s disease (AD) and even mild cognitive impairment (MCI). The Frontal Behavioral Inventory (FBI) was specifically developed to capture the behavioral and personality changes in bvFTD; it has also been modified into a self-administered caregiver questionnaire (FBI-mod). We examined the utility of the FBI-mod in differentiating bvFTD (n = 26), primary progressive aphasia (PPA) (n = 7), AD (n = 53), and MCI (n = 50) patients, and investigated how the FBI-mod may be associated with neuropsychological measures. The bvFTD patients scored significantly higher as compared to all other patient groups on the FBI-mod Total (p < 0.005), Negative (p < 0.005), and Positive (p < 0.01) scores. The cut-off point for the FBI-mod Total score that best discriminated the bvFTD and AD patients in our sample was 16, thus substantially lower than reported for the original FBI. For the bvFTD group, only mild correlations emerged between the FBI-mod and the cognitive measures. However, significant correlations between the FBI-mod and depressive symptoms as measured by the BDI-II were found for bvFTD. This suggests that while behavioral symptoms appear independent from cognitive deficits in bvFTD, they may nevertheless be interrelated with depressive symptoms. We conclude that the FBI-mod is an easily administered behavioral scale that can aid in differential diagnosis of bvFTD and should be used in clinical practice. The FBI-mod may further be considered as an outcome measure in clinical trials.
KarttunenK, KarppiP, HiltunenA, VanhanenM, ValimakiT, MartikainenJ, ValtonenH, SiveniusJ, SoininenH, HartikainenS, SuhonenJ, PirttilaT, ALSOVA study group (2011) Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer’s disease. Int J Geriatr Psychiatry26, 473–482.
5.
JohnsonJK, HeadE, KimR, StarrA, CotmanCW (1999) Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol56, 1233–1239.
6.
ZhaoQF, TanL, WangHF, JiangT, TanMS, TanL, XuW, LiJQ, WangJ, LaiTJ, YuJT (2016) The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: Systematic review and meta-analysis. J Affect Disord190, 264–271.
7.
PetersenRC, CaraccioloB, BrayneC, GauthierS, JelicV, FratiglioniL (2014) Mild cognitive impairment: A concept in evolution. J Intern Med275, 214–228.
8.
Van der MusseleS, Le BastardN, VermeirenY, SaerensJ, SomersN, MarienP, GoemanJ, De DeynPP, EngelborghsS (2013) Behavioral symptoms in mild cognitive impairment as compared with Alzheimer’s disease and healthy older adults. Int J Geriatr Psychiatry28, 265–275.
9.
ForresterSN, GalloJJ, SmithGS, LeoutsakosJM (2016) Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. Am J Geriatr Psychiatry24, 117–125.
10.
RosenbergPB, MielkeMM, ApplebyBS, OhES, GedaYE, LyketsosCG (2013) The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry21, 685–695.
11.
MathiasJL, MorphettK (2010) Neurobehavioral differences between Alzheimer’s disease and frontotemporal dementia: A meta-analysis. J Clin Exp Neuropsychol32, 682–698.
12.
KerteszA, DavidsonW, FoxH (1997) Frontal behavioral inventory: Diagnostic criteria for frontal lobe dementia. Can J Neurol Sci24, 29–36.
BlairM, KerteszA, Davis-FaroqueN, HsiungGR, BlackSE, BouchardRW, GauthierS, GuzmanDA, HoganDB, RockwoodK, FeldmanH (2007) Behoural measures in frontotemporal lobar dementia and other dementias: The utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study. Dement Geriatr Cogn Disord23, 406–415.
15.
Boutoleau-BretonniereC, LebouvierT, VolteauC, JaulinP, LacomblezL, DamierP, Thomas-AnterionC, VercellettoM (2012) Prospective evaluation of behavioral scales in the behoral variant of frontotemporal dementia. Dement Geriatr Cogn Disord34, 75–82.
16.
KerteszA, NadkarniN, DavidsonW, ThomasAW (2000) The Frontal Behavioral Inventory in the differentialdiagnosis of frontotemporal dementia. J Int Neuropsychol Soc6, 460–468.
17.
KonstantinopoulouE, AretouliE, IoannidisP, KaracostasD, KosmidisMH (2013) Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer’s disease: Evidence from the Frontal Behoral Inventory. Int J Geriatr Psychiatry28, 939–946.
18.
MarczinskiCA, DavidsonW, KerteszA (2004) A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol17, 185–190.
19.
MilanG, LamenzaF, IavaroneA, GaleoneF, LoreE, de FalcoC, SorrentinoP, PostiglioneA (2008) Frontal Behavioural Inventory in the differential diagnosis of dementia. Acta Neurol Scand117, 260–265.
20.
PachalskaM, BidzanL, LukowiczM, BidzanM, MarkiewiczK, JastrzebowskaG, TalarJ (2011) Differential diagnosis of behavioral variant of fronto-temporal dementia (bvFTD). Med Sci Monit17, R311–R321.
21.
BoxerAL, LiptonAM, WomackK, MerrileesJ, NeuhausJ, PavlicD, GandhiA, RedD, Martin-CookK, SvetlikD, MillerBL (2009) An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord23, 211–217.
22.
Diehl-SchmidJ, ForstlH, PerneczkyR, PohlC, KurzA (2008) A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry23, 754–759.
23.
FingerEC, MacKinleyJ, BlairM, OliverLD, JessoS, TartagliaMC, BorrieM, WellsJ, DziobekI, PasternakS, MitchellDG, RankinK, KerteszA, BoxerA (2015) Oxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability. Neurology84, 174–181.
24.
HerrmannN, BlackSE, ChowT, CappellJ, Tang-WaiDF, LanctotKL (2012) Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiatry20, 789–797.
25.
JessoS, MorlogD, RossS, PellMD, PasternakSH, MitchellDG, KerteszA, FingerEC (2011) The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain134, 2493–2501.
VercellettoM, Boutoleau-BretonniereC, VolteauC, PuelM, AuriacombeS, SarazinM, MichelB, CouratierP, Thomas-AnterionC, VerpillatP, GabelleA, GolfierV, CeratoE, LacomblezL, French research network on Frontotemporal dementia (2011) Memantine in behavioral variant frontotemporal dementia: Negative results. J Alzheimers Dis23, 749–759.
28.
Heidler-GaryJ, GottesmanR, NewhartM, ChangS, KenL, HillisAE (2007) Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer’s disease. Dement Geriatr Cogn Disord23, 184–193.
29.
Heidler-GaryJ, HillisAE (2007) Distinctions between the dementia in amyotrophic lateral sclerosis with frontotemporal dementia and the dementia of Alzheimer’s disease. Amyotroph Lateral Scler8, 276–282.
30.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
31.
WinbladB, PalmerK, KivipeltoM, JelicV, FratiglioniL, WahlundLO, NordbergA, BackmanL, AlbertM, AlmkvistO, AraiH, BasunH, BlennowK, de LeonM, DeCarliC, ErkinjunttiT, GiacobiniE, GraffC, HardyJ, JackC, JormA, RitchieK, van DuijnC, VisserP, PetersenRC (2004) Mild cognitive impairment–beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med256, 240–246.
32.
FolsteinMF, FolsteinSE, McHughPR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
33.
LezakMD, HowiesonDB, LoringDW (2004), Neuropsychological Assessment (4th ed.), Oxford University Press, New York.
34.
MorrisJC, HeymanA, MohsRC, HughesJP, van BelleG, FillenbaumG, MellitsED, ClarkC (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology39, 1159–1165.
35.
WechslerD (2005) Wechsler Adult Intelligence Scale - Third Edition: Finnish Manual, Psykologien kustannus Oy, Helsinki.
ReitanRM (1958) Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills8, 271–276.
38.
GoldenCJ (1978) Stroop Color and Word Test, Stoelting Company, Chicago.
39.
BeckAT, SteerRA, BrownGK (1996) Manual for the Beck Depression Inventory-II. The Psychological Corporation, San Antonio, TX.
40.
BenjaminiY, HochbergY (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B57, 289–300.
41.
CummingsJL, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2314.
42.
MonasteroR, MangialascheF, CamardaC, ErcolaniS, CamardaR (2009) A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis18, 11–30.
43.
TifrateneK, RobertP, MetelkinaA, PradierC, DartiguesJF (2015) Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology85, 331–338.
44.
BidzanL, BidzanM, PachalskaM (2016) The effects of intellectual, physical, and social activity on further prognosis in mild cognitive impairment. Med Sci Monit22, 2551–2560.
45.
WilsonRS, BarnesLL, AggarwalNT, BoylePA, HebertLE, Mendes de LeonCF, EvansDA (2010) Cognitive activity and the cognitive morbidity of Alzheimer disease. Neurology75, 990–996.
46.
YatesLA, ZiserS, SpectorA, OrrellM (2016) Cognitive leisure activities and future risk of cognitive impairment and dementia: Systematic review and meta-analysis. Int Psychogeriatr28, 1791–1806.
47.
KerteszA, DavidsonW, McCabeP, MunozD (2003) Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord17, 223–229.
48.
DillonC, SerranoCM, CastroD, LeguizamonPP, HeiseckeSL, TaraganoFE (2013) Behavioral symptoms related to cognitive impairment. Neuropsychiatr Dis Treat9, 1443–1455.
49.
ChakrabartyT, SepehryAA, JacovaC, HsiungGY (2015) The prevalence of depressive symptoms in frontotemporal dementia: A meta-analysis. Dement Geriatr Cogn Disord39, 257–271.
50.
HongistoK, VaatainenS, MartikainenJ, HallikainenI, ValimakiT, HartikainenS, SuhonenJ, KoivistoAM (2015) Self-rated and caregiver-rated quality of life in Alzheimer disease with a focus on evolving patient ability to respond to questionnaires: 5-year prospective ALSOVA Cohort Study. Am J Geriatr Psychiatry23, 1280–1289.
51.
PolettiM, LucettiC, LogiC, BaldacciF, CiprianiG, NutiA, BorelliP, BonuccelliU (2013) Cognitive correlates of negative symptoms in behavioral variant frontotemporal dementia: Implications for the frontal lobe syndrome. Neurol Sci34, 1893–1896.
52.
StokholmJ, VogelA, GadeA, WaldemarG (2005) The executive interview as a screening test for executive dysfunction in patients with mild dementia. J Am Geriatr Soc53, 1577–1581.
53.
Garcia-AlbercaJM, LaraJP, BerthierML, CruzB, BarbanchoMA, GreenC, Gonzalez-BaronS (2011) Can impairment in memory, language and executive functions predict neuropsychiatric symptoms in Alzheimer’s disease (AD)? Findings from a cross-sectional study. Arch Gerontol Geriatr52, 264–269.
54.
HallikainenI, KoivistoAM, PaajanenT, HiltunenA, KarppiP, VanhanenM, ValimakiT, HerukkaSK, SoininenH, HanninenT (2012) Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer’s disease: Kuopio ALSOVA Study. Dement Geriatr Cogn Dis Extra2, 209–218.
55.
PerriR, MonacoM, FaddaL, CaltagironeC, CarlesimoGA (2014) Neuropsychological correlates of behavioral symptoms in Alzheimer’s disease, frontal variant offrontotemporal, subcortical vascular, and Lewy body dementias: A comparative study. J Alzheimers Dis39, 669–677.
56.
RosenbergPB, MielkeMM, ApplebyB, OhE, LeoutsakosJM, LyketsosCG (2011) Neuropsychiatric symptoms in MCI subtypes: The importance of executive dysfunction. Int J Geriatr Psychiatry26, 364–372.
57.
ZahodneLB, TremontG (2013) Unique effects of apathy and depression signs on cognition and function in amnestic mild cognitive impairment. Int J Geriatr Psychiatry28, 50–56.
58.
BrodatyH, HeffernanM, DraperB, ReppermundS, KochanNA, SlavinMJ, TrollorJN, SachdevPS (2012) Neuropsychiatric symptoms in older people with and without cognitive impairment. J Alzheimers Dis31, 411–420.
59.
IsmailZ, SmithEE, GedaY, SultzerD, BrodatyH, SmithG, Aguera-OrtizL, SweetR, MillerD, LyketsosCG, ISTAART Neuropsychiatric Symptoms Professional Interest Area (2016) Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement12, 195–202.
60.
OssenkoppeleR, PijnenburgYA, PerryDC, Cohn-SheehyBI, ScheltensNM, VogelJW, KramerJH, van der VliesAE, JoieRL, RosenHJ, van der FlierWM, GrinbergLT, RozemullerAJ, HuangEJ, van BerckelBN, MillerBL, BarkhofF, JagustWJ, ScheltensP, SeeleyWW, RabinoviciGD (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: Clinical, neuroimaging and pathological features. Brain138, 2732–2749.
61.
WarrenJD, FletcherPD, GoldenHL (2012) The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol8, 451–464.
62.
WoodwardM, JacovaC, BlackSE, KerteszA, MackenzieIR, FeldmanH, ACCORD investigator group (2010) Differentiating the frontal variant of Alzheimer’s disease. Int J Geriatr Psychiatry25, 732–738.
63.
MillerJB, BanksSJ, LegerGC, CummingsJL (2014) Randomized controlled trials in frontotemporal dementia: Cognitive and behavioral outcomes. Transl Neurodegener3, 12-9158-3-12. eCollection 2014.
